伴有剖腹产史的单蒂横行腹直肌肌皮瓣乳房再造术

目的 探讨伴有剖宫产史的单蒂横行腹直肌肌皮瓣乳房再造术的手术方法、临床可行性及应用技术.方法 对9例剖宫产后不同时间的乳腺癌患者,在乳腺癌仿根治术后,采用即刻转移对侧单蒂横行腹直肌肌皮瓣进行乳房再造手术,腹壁横梭形皮瓣的上切口位于脐上l～2 cm,下切口于下腹壁纵行切口瘢痕的中下1/3,切取以对侧腹直肌为单蒂的下腹壁皮瓣,转移至胸壁缺损部位,修整塑造乳房外形.结果 9例乳房再造术患者转移的单蒂横行腹直肌肌皮瓣完全成活,再造乳房形态自然,外形逼真,无皮瓣坏死发生.2例保留乳头者发生乳头缺血,部分坏死脱落后愈合.结论 单蒂横行腹直肌肌皮瓣乳房再造术,对于有剖宫产史的乳腺癌患者并非绝对禁忌证,在做好术前充分评估的基础上,可以安全选择应用.     

乳腺癌术后单蒂横行腹直肌肌皮瓣乳房再造

目的：探讨下腹部单蒂横行腹直肌肌皮瓣（Transverse Rectus Abdomials Myocataneous，TRAM）在乳腺癌术后乳房再造中的应用。方法：2004～2007年，对13例乳腺癌患者应用对侧单蒂TRAM皮瓣进行乳房再造，其中Ⅰ期再造7例，Ⅱ期再造6例，乳腺癌根治术后1例，乳腺癌改良根治术后12例。1例Ⅱ期进行乳头乳晕再造。9例供区下腹部应用涤纶补片加强腹壁预防腹壁软弱和腹壁疝形成。结果：2例Ⅱ期再造术后TRAM皮瓣小部分坏死，1例Ⅱ期再造术后TRAM皮瓣部分皮下脂肪硬结伴部分液化，1例对侧下腹壁轻度膨隆不适，无腹壁疝。结论：乳腺癌术后应用单蒂TRAM皮瓣乳房再造术是一种较为有效、简单和安全的方法，应用涤纶补片加强腹壁可以有效预防腹壁软弱和腹壁疝形成。     

10例保留皮肤的乳腺癌改良根治术后即时TRAM皮瓣乳房再造体会

目的 总结保留皮肤乳腺癌改良根治术后即时乳房再造方法的治疗体会.方法 笔者所在医院2008年5月至2011年12月期间对10例早期乳腺癌患者行保留大部分皮肤的改良根治术,同时应用下腹部腹直肌带蒂肌皮瓣(TRAM)行即时乳房再造,就该10例患者的临床资料进行回顾性分析.结果 10例患者中1例TRAM皮瓣部分坏死,1例乳头部分坏死,1例再造乳房乳尾部脂肪部分坏死伴腋下伤口感染;无腹壁切口疝发生,无全部TRAM皮瓣坏死病例.术后患者对再造乳房形态评价非常满意5例,比较满意4例,不满意1例.结论 保留皮肤的乳腺癌改良根治术后即时TRAM皮瓣乳房再造方法的切口小,再造乳房形态好,是一种安全有效的治疗早期乳腺癌患者的方法.     

剖宫产术后行横行腹直肌肌皮瓣乳房再造的应用策略

目的 探讨剖宫产后瘢痕者行横行腹直肌(transverse rectus abdominis myocutaneous,TRAM)肌皮瓣乳房再造的可行性和手术策略.方法 对12例有剖宫产史的乳腺癌患者实施TRAM肌皮瓣乳房再造术.所有患者的TRAM肌皮瓣应用危险因素评分均为0.5分,Ⅱ类.采用腹部倒梯形手术切口,切口上缘下距脐2～3 cm,对1例腹部纵切口瘢痕较长者采用腹直肌双蒂,其余均为患乳对侧腹直肌单蒂,并携带同侧腹直肌前鞘,对腹直肌和前鞘缺损以聚丙烯网片修补.结果 全部12例皮瓣成活,无腹部并发症发生,随访3～52个月,满意率达100％.结论 带剖宫产瘢痕者行TRAM肌皮瓣乳房再造需严格选择病例,并要求制定相应的手术策略.     

乳腺癌切除术后乳房再造

目的 探讨乳腺癌切除术后乳房再造的方法及时间.方法 总结30例不符合保乳条件的乳腺癌病例,乳房切除术后假体置人乳房再造16例,下腹部横行腹直肌肌皮瓣(TRAM瓣)乳房再造10例,背阔肌肌皮瓣乳房再造4例.其中即刻乳房再造27例,延期乳房再造3例.结果 16例假体置入乳房再造术后外观评价均为良,未出现术后并发症.10例TRAM瓣乳房再造术后发生皮瓣部分坏死2例,腹壁疝1例,术后外观评价7例为良.2例为较好,1例为差.4例背阔肌肌皮瓣再造术后外观评价为良.结论 乳房再造术是乳腺癌综合治疗不可忽视一部分,对于有强烈的保乳愿望,而又不符合保乳条件的患者,乳房再造术是一种较好的选择.即刻乳房再造优于延迟乳房再造.乳房再造的方法选择要因人而异.局部晚期乳腺癌患者可以选择性进行即刻乳房再造术.     

即刻及延期乳房再造方法的选择

目的回顾总结乳腺癌根治术后应用单纯假体植入、Becker可扩张假体植入和单蒂腹部横形腹直肌肌皮瓣（TRAM）移植、扩大背阔肌肌皮瓣（ELDF）移植乳房再造术的经验,探讨手术的适应证、方法和效果。方法自2002年7月至2005年10月,共67例患者进行了乳腺癌根治术后乳房再造术。即刻乳房再造56例：单纯假体植入38例、Becker可扩张假体植入16例、单蒂TRAM移植2例。延期乳房再造11例：单蒂TRAM移植6例、ELDF移植4例、Becker可扩张假体植入1例。结果手术效果满意,优良率超过90％。5例患者出现轻微并发症：皮瓣局灶性坏死2例,保留的乳头乳晕部分坏死1例,血清肿2例。结论单纯假体植入用于即刻乳房再造,适用于乳房较小、行保留皮肤的乳腺癌根治术后的患者,不宜用于延期乳房再造;可扩张假体植入即刻乳房再造适用于乳房较大或改良乳腺癌根治术的患者,同时可扩张假体植入延期乳房再造可用于皮肤、肌肉保留较好的乳腺癌根治患者;TRAM和ELDF皮瓣移植乳房再造是自体组织移植,其安全性高,可用于即刻和延期乳房再造。     

乳房再造术的临床研究

目的 回顾总结了乳癌根治术后应用单纯假体植入、Becker可扩张假体植入和带蒂腹部横形腹直肌肌皮瓣(TRAM)移植、扩大的背阔肌肌皮瓣(ELDF)移植乳房再造术的经验,探讨手术的适应征、方法和效果.方法 16例行保留皮肤的乳癌根治术一期假体植入乳房再造;13例行Becker可扩张假体植入一期乳房再造;4例行单蒂下腹部横形腹直肌肌皮瓣(TRAM)移植乳房再造手术,其中2例为一期再造,另2例为二期再造.应用Becker可扩张假体行二期乳房再造1例.扩大背阔肌肌皮瓣(ELDF)移植二期乳房再造1例.结果 手术效果满意,优良率超过90%.3例病人出现轻微并发症,其中1例皮瓣局灶坏死,一例出现保留的乳头乳晕部分坏死,1例出现血清肿.结论 单纯假体植入适用于瘦小病人,对侧乳房小且没有明显下垂.优点是不增加额外瘢痕,术后恢复快;可扩张假体植入乳房再造适用于乳房大或改良乳癌根治术的患者,此法结合了单纯假体植入法和组织扩张术乳房再造术的优点;TRAM和ELDF皮瓣移植乳房再造的优点是自体组织移植,安全、手术效果好.     

乳腺癌术后横行腹直肌皮瓣乳房再造的适应证剖析

目的探讨乳腺癌术后下腹部横行腹直肌（transverse rectus abdominal myocutaneous,TRAM）皮瓣乳房再造术的适应证的选定,并进行临床剖析。方法对17例乳腺癌切除术后患者应用对侧单蒂TRAM皮瓣进行乳房再造,其中I期再造者7例,Ⅱ期再造10例,均为乳腺癌改良根治术后患者。9例Ⅱ期进行乳头、乳晕再造。12例供区下腹部应用涤纶补片加固腹壁以预防腹壁软弱和腹壁疝形成。由多学科诊疗小组对适应证选择,并进行总结和分析。结果17例经过5个月至6年的观察,2例Ⅱ期再造术后,TRAM皮瓣的皮肤发生小面积坏死,1例对侧下腹壁轻度膨隆,无腹壁疝,经过对症处理,17例均取得较好疗效。结论对于乳腺癌术后具有适应证的患者应用横行TRAM皮瓣乳房再造术是一种较为有效和安全的方法。严格选定适应证,是乳房再造成功的关键。     

几种乳房再造术的临床应用体会

目的：探讨乳腺癌根治术后应用单纯假体植入、可扩张假体植入和带蒂腹部横形腹直肌肌皮瓣（TRAM）移植乳房再造的适应证、手术方法、手术效果。方法：本组共24例病例。14例乳腺癌患者行保留皮肤的乳腺癌根治术，Ⅰ期行假体植入乳房再造；6例采用改良乳腺癌根治可扩张假体植入Ⅰ期乳房再造；4例接受单蒂下腹部横形腹直肌肌皮瓣（TRAM）移植乳房再造手术，其中2例为Ⅰ期再造，另2例为Ⅱ期乳房再造。结果：手术效果较满意，2例出现轻微并发症，其中1例皮瓣局灶坏死，另1例出现乳头乳晕部分坏死。结论：单纯假体植入适用于乳房小，没有明显下垂的瘦小病人。优点是不增加额外瘢痕，术后恢复快；可扩张假体植入乳房再造适用于乳房大或改良乳腺癌根治术的患者，此法结合了单纯假体植入法和组织扩张的优点：TRAM皮瓣移植乳房再造的优点是自体组织移植，安全、手术效果好。     

早期乳腺癌患者术后应用整形技术的临床观察

目的:观察并总结采用整形美容技术对早期乳腺癌患者进行手术治疗的临床经验。方法:回顾性分析2007年3月～2011年2月期间我院收治的86例术前分期为I～II期的乳腺癌患者,分别应用腹直肌肌皮瓣(TRAM)、腹壁下动脉穿支皮瓣(DIEP)、TRAM与DIEP联合皮瓣、背阔肌肌皮瓣(LDF)加或不加假体、硅凝胶乳房假体、保留乳头乳晕复合体的方法对其中74例施行乳腺癌改良根治术的患者进行乳房整形手术,总结该74例患者的临床病例资料,对术后美容效果及远期预后进行评估。结果:患者均为女性,年龄分布35～68岁,平均(48.2±6.5)岁,中位年龄46岁。12例患者仅采用改良根治术治疗,74例应用乳房整形技术的患者中,采用腹直肌肌皮瓣(TRAM)进行乳房再造26例,腹壁下动脉穿支皮瓣(DIEP)乳房再造术6例,TRAM与DIEP联合皮瓣行乳房再造术8例,背阔肌肌皮瓣(LDF)加或不加假体进行乳房再造20例,硅凝胶乳房假体进行乳房再造8例,保留乳头乳晕复合体进行乳房再造6例。不同整形技术对乳腺癌术后的恢复及并发症的发生率有影响,差异存在统计学意义,采用整形技术及单纯根治术治疗,乳腺癌术后恢复及并发症发生率的差异未发现统计学意义。术后随访10～16个月,未发现局部和区域肿瘤复发,无伤口、皮肤坏死和感染,未发现死亡病例,继续随访观察。结论:I、II期乳腺癌患者在行改良根治术后,应用乳房整形技术治疗是安全、有效的,腹直肌肌皮瓣乳房再造术进行乳房美容的效果最好,乳房整形术术后并发症较传统单纯乳腺癌改良根治术发生率无明显变化,具有广阔的应用前景。     

乳房体积测量方法的比较研究

目的：比较各类乳房体积测量方法,为临床应用提供参考。方法以“breast volume”、“breast measurement”和“breast volumetry”为关键词,检索Pubmed和万方数据库,筛选出以乳房体积测量为主题的文献。回顾、整理各类乳房体积测量方法,并分析其原理,比较其准确性、经济性和操作可行性。结果自1970年7月至2013年5月,总共有46篇以乳房体积测量的文章符合入选标准。目前已被报道的乳房体积测量方法共有9种,可以根据其测量原理分为三类：影像法,包括MRI、超声和CT测量;自然法,包括3D建模、排水体积法和胸模法;几何法,包括Grossman-Roudner、人体测量计算和X线摄片。结论9种测量方法中,3D建模和MRI测量法,因准确性较高,又没有明显的副作用,可以用来为术前计划提供参考;Grossman-Roudner模具测量法和人体测量法虽可靠性有所降低,但经济简便,可以使用在较大样本量的临床研究中。     

Routine Operative Breast Endoscopy During Lumpectomy

Background: Lumpectomy for the management of breast cancer is commonly directed by mammography or ultrasound. We hypothesized that fluid-producing ducts would likely connect to the site of the known cancerous or precancerous lesion and that endoscopic evaluation might reveal unsuspected additional disease.Methods: All women undergoing lumpectomy in a single surgeon practice from January 2000 to August 2001 were evaluated for fluid production from the nipple at the time of lumpectomy. All fluid-producing ducts were cannulated and endoscoped with a 0.9-mm Acueity microendoscope.Results: Of the 201 patients (16 with atypical ductal hyperplasia, 52 with ductal carcinoma-in-situ, and 133 with stage 1 or 2 breast cancers), 150 (74.6%) could be successfully dilated and scoped. Additional lesions outside the anticipated lumpectomy were identified in 41% (n = 83) of cases. If successful, the chances for a positive margin for cancer decreased from 23.5% to only 5.0%. Endoscopy proved to be a useful adjunct in this series of patients because it identified all cases of extensive intraductal component in early-stage breast cancer.Conclusions: Routine operative breast endoscopy can reduce the need for re-excision lumpectomy. It also finds substantially more cancerous and precancerous disease than anticipated by routine preoperative mammography and ultrasound.     

Contribution of breast density to the volume of the augmented breast: A preliminary study

BACKGROUND:

Prediction of soft tissue contribution to the shape, volume and texture of the augmented breast proves to be an ever-challenging, uncontrollable variable. Similarly, the understanding of the contribution of breast density in breast augmentation has been elusive and, generally, not well studied.

OBJECTIVE:

With the aid of three-dimensional photographic analysis, the present preliminary study examined the contribution of differing breast densities to the overall volume of the augmented breast.

METHODS:

All patients undergoing primary augmentation over a six-month period were included in the study. To standardize technique and implant type, all patients received saline-filled moderate-profile implants, which were placed partially underneath the pectoralis muscle through a lower pole approach. Photographic analysis of the breast volume was completed preoperatively and, subsequently, at a minimum of six months postoperatively. Preoperatively, each breast was also assigned to one of four classes of increasing mammographic density, as judged by the mammographic radiologist (fatty, moderately dense, heterogeneously dense and extremely dense). Postoperative breast volumes were, subsequently, correlated to mammographic densities.

RESULTS:

Thirty-eight augmented breasts in 21 patients were examined. The average volume gain based on the implant size used was 92.7%. Heterogeneously dense breasts comprised 68% of the total breasts and showed an average volume gain of 100.67%, extremely dense breasts comprised 26% of the total breasts and showed an average volume gain of 97.3%, and moderately dense breasts comprised 5% of the total breasts with an average gain of 100.04%. There was no significant difference between the augmented breast volumes and the respective expected volumes (combined preaugmented breast volumes and implant volumes; P=0.3483). Additionally, no statistical difference was found between the density classes and the expected augmented volumes.

CONCLUSION:

No statistical difference was found between expected and actual augmented breast volumes among or between four different breast density classes. Thus, one would expect that the soft tissue compression or the response of the impression of the implant on the parenchyma, would not be statistically different among classes. Additionally, compressive atrophy, as seen with atrophy of the breasts over time, would be expected to be multifactorial and not uniquely independent to breast density. However, longitudinal analysis is needed to study the durability of breast shape relative to breast density.     

Virtual 3-dimensional modeling as a valuable adjunct to aesthetic and reconstructive breast surgery

Three-dimensional (3D) imaging technology currently is used by various commercial industries as a method for analyzing objects and shapes. Recent work from our group and others offer data to support the use of 3D imaging as a valuable tool in aesthetic and reconstructive breast surgery. We have developed a system for creating 3D breast models that provides clinical data that can help guide surgical management. With 3D breast models, surgeons are able to visually assess the size, shape, contour, and symmetry of the breast, as well as obtain quantitative breast measurements and volumetric calculations. Three-dimensional imaging may be applied to various plastic surgery procedures including breast reconstruction with implant/tissue expanders, local flap reconstruction, free-flap reconstruction, breast augmentation, and breast reduction surgery. The novel application of 3D imaging in these settings represents a significant advance from traditional approaches to aesthetic and reconstructive breast surgery in which surgical procedures are based on 2-dimensional photographs and visual size estimates.     

Occult breast carcinoma in patients undergoing reduction mammaplasty

Seven patients who had breast reduction surgery and whose preoperative physical examinations were unremarkable were found to have brest carcinoma. In the five in whom mastectomy was performed, most closures were difficult, and in one patient bilateral mastectomy was complicated by wound dehiscence. In only one of these seven was it possible to obtain information regarding the hormonal binding status of the tumor cells. These and other sequelae would not have occured had the tumors been diagnosed before operation. Because physical examination alone is not sufficiently sensitive for the diagnosis of breast cancer, we suggest that mammography be included in the evaluation of patients consulting surgeons for breast reduction.     

Case report of a definitive autologous reconstruction in a patient requiring immediate postoperative anticoagulation and reduced operative time

IntroductionThe available options for post-mastectomy reconstruction in a patient requiring abbreviated operative times and immediate and sustained post-operative anticoagulation are limited.Presentation of caseA 50 year old woman with a history of multiple deep venous thromboses (DVTs) and pulmonary embolisms (PEs) requested a bilateral prophylactic mastectomy and immediate reconstruction. She had a history of multiple breast biopsies demonstrating atypia and two sisters with premenopausal breast cancer. Her hematologist requested that her anticoagulation be held for the minimal amount of time and that her theater times be kept as short as possible. As such, we felt that she was not a candidate for traditional implant-based reconstruction nor autologous flap surgery. Instead, we made use of a recently described single-stage autologous modified Goldilocks procedure to complete her bilateral mastectomy and reconstruction in 150 min. She was anticoagulated in the operating room and was restarted on her preoperative regimen twelve hours after surgery. She suffered no post-operative complications.DiscussionThere is minimal published literature discussing immediate post-mastectomy reconstruction in the anticoagulated patient. Most reconstructive surgeons find these patients unsuitable for traditional reconstructive techniques. In the current case, we utilized a recently described single-stage autologous technique which allowed us to avoid the bleeding complications associated with the muscular dissection required with implant and flap-based reconstructive surgery. The extirpation and reconstruction was completed in 150 min which is significantly quicker than traditional reconstructions.ConclusionThe modified Goldilocks procedure is an excellent option in the patient who requires immediate postoperative anticoagulation and abbreviated operative times.     

Predicting breast reduction weight using the mass of breast ptosis

BACKGROUND:

The preoperative prediction of therapeutic breast reduction weights, to achieve both relief of breast weight symptoms and yet achieve excellent breast shape, remains a challenge.

OBJECTIVES:

To design a simple clinical method to preoperatively predict and quantify therapeutic breast reduction weights.

METHODS:

In 31 women who underwent therapeutic bilateral reduction mammaplasty, the mass of the hypertrophic breast hanging below the inframammary fold was preoperatively weighed and then compared with the mass of the reduction specimen. Thirty patients underwent breast reduction using a superomedial nipple-areolar pedicle. Postoperative breast weight-related symptoms and breast shape findings were then noted. Statistical analysis relied on mean, SD, sample size, Mann-Whitney test for medians, Levene’s test for variances and regression analysis.

RESULTS:

The average clinical follow-up was 160 days, with all patients achieving satisfactory breast size and shape from both the patient and surgeon’s perspectives. All patients reported improvement of back pain, shoulder pain and lower neck pain. Two breasts developed delayed healing of the lateral skin flap, necessitating debridement and reclosure, followed by uneventful ongoing healing. There was no significant difference in preoperative ptotic breast mass and resectional breast mass (all P>0.05).

CONCLUSIONS:

Simple preoperative weighing of the ptotic portion of the hypertrophic breast can serve as a goal for the reduction weight, while creating pleasing breast proportions and improving breast weight-related symptoms. Preoperative quantification of the ptotic breast mass may guide the reduction technique and assist insurance precertification efforts.     

三平面法隆乳术在乳房萎缩伴下垂矫正术中的应用

目的 探讨应用胸大肌后放置假体,并于胸大肌中央部位切开,形成假体表面胸肌-腺体-胸肌三平面覆盖的方法,矫正乳房萎缩伴下垂的效果.方法 选择环乳晕切口,进行乳房上象限腺体表面分离及真皮帽折叠固定.再由乳腺外下象限边缘进入乳房后间隙,于新的乳头、乳晕水平将胸大肌横行及纵行部分离断,将假体植入胸大肌后.于术前及术后对乳房各解剖径线进行标准化测量.结果 2011年6 ～12月,应用上述方法行乳房上提联合隆乳手术14例,患者术后乳房上极形态、乳房凸度及乳头、乳晕位置均得到了明显改善,且无严重并发症发生.术后随访6～12个月,乳房形态良好.结论 三平面法能够在不离断胸大肌起点及止点的情况下,保证假体在乳头、乳晕水平良好的凸度,避免了乳房下垂联合隆乳手术时易发生的双泡畸形或阶梯现象,且损伤较小.     

乳癌术后不同乳房再造术式的临床应用

目的探讨适合乳癌术后各种乳房再造术式的适应证。方法对我院2003至2005年收治的44例、45只乳癌术后乳房再造的患者,根据不同情况分别采用扩张器/假体置入(5只)、背阔肌肌皮瓣 假体置入(13只)、背阔肌肌皮瓣(3只)、DIEP皮瓣(6只)、单蒂TRAM瓣(10只)及劈开的双蒂TRAM瓣(8只)等方法进行乳房再造,分析各手术方法的适应证。结果应用皮瓣乳房再造40只,皮瓣全部成活;1只应用扩张器/假体乳房再造术后,注射壶部表皮坏死;1只应用背阔肌 假体乳房再造术后半年出现假体破裂伴局部感染;1只应用DIEP乳房再造术后,出现皮瓣下积液;2只部分皮瓣坏死。术后随访3个月至半年,医生及患者对乳房形态均较满意。所有应用腹部皮瓣的患者均无腹壁疝发生。结论6种乳房再造技术基本满足了我国女性乳癌术后各个时期各种条件再造乳房的要求,整形外科技术的改进以及新材料的应用扩大了乳房再造的适应证。     

80例乳房再造术后并发症临床分析

目的　对应用不同术式行乳房再造术的 80例患者进行分析讨论。方法　从皮瓣坏死率、腹壁疝发生率、腹壁张力、感觉等分析了应用假体 ,背阔肌肌皮瓣 (latissimusdorsimusculocutaneousflap ,LDFM瓣 )、带蒂横行腹直肌肌皮瓣 (transverserectusabdominismusculocutaneousflap ,TRAM瓣 )、臀大肌肌皮瓣 (gluteusmaximmusculocutaneousflap ,GMM瓣 )、腹壁下动脉穿支皮瓣 (deepinferiorepigastricarteryperforatorflap ,DIEP瓣 )等方法并发症产生的原因及预防措施。结果　LDFM瓣最主要的并发症是血清肿 (12 5 % )。LDFM、TRAM、DIEP三者中TRAM瓣坏死率最高 (2 6 % ) ,1例GMM瓣再造后皮瓣部分坏死 ,19例应用假体者包膜挛缩率为 2 1%。结论　乳房再造的并发症与选择的术式有关 ,术者应熟悉乳房再造的各种皮瓣的解剖 ,尽量应用自体组织再造乳房。